← The Commons
All The Commons episodes →
Slamming Cancer: A Conversation with Steve Potts, CEO of SLAM BioTherapeutics
The Commons · 2024-06-18 · 10 min
Episode notes
Commons host, Thomas Osha, catches up with serial entrepreneur, Steve Potts, to discuss his latest venture, SLAM BioTherapeutics. Slam Bio is developing a platform of first-in-class monoclonal antibody therapies and antibody-drug conjugates (ADCs) targeting cancer, beginning with blood cancers. The conversation took place at the BIO International Conference 2024 in San Diego June 4-6, 2024.
More from The Commons
All episodes →- Innovating by Design: Matt Ellsworth on Arizona's Bioscience Roadmap42 / 100
- How Arizona Built a Bioscience Economy at State Scale: A Conversation with Mary O'Reilly47 / 100
- How Breakthroughs Get Built: A Conversation with Steve Potts49 / 100
- A Platform For Discovery and Impact: A Conversation with John Swartley
- Creating Impact from Innovation - The Evolving Role of the University City Science Center: A Conversation with CEO, Tiffany Wilson